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CRAC motifSeveral proteins that interact with cholesterol have a highly conserved sequence, corresponding to the
cholesterol recognition/interaction amino acid consensus. Since cholesterol has been proposed to modulate
both oligomerization and insertion of the pro-apoptotic protein BAX, we investigated the existence of such a
motif in the BAX sequence. Residues 113 to 119 of the recombinant BAX α5-helix, LFYFASK, correspond with
the sequence motif described for the consensus pattern, –L/V-(X)(1–5)-Y-(X)(1–5)-R/K. Functional
characterization of the point mutations, K119A, Y115F, and L113A in BAX, was performed in liposomes
supplemented with cholesterol, comparing binding, integration, and pore forming activities. Our results show
that the mutations Y115F and L113A changed the cholesterol-dependent insertion observed in the wild type
protein. In addition, substitutions in the BAX sequence modiﬁed the concentration dependency of
carboxyﬂuorescein release in liposomes, although neither pore activity of the wild type or of any of the
mutants signiﬁcantly increased in cholesterol-enriched liposomes. Thus, while it is likely that the putative
CRAC motif in BAX accounts for its enhanced insertion in cholesterol-enriched liposomes; the pore forming
properties of BAX did not depend on cholesterol content in the membranes, albeit those mutations changed
the pore channeling activity of the protein.nsition pore; CRAC, cholesterol
5; fax: +52 55 5573 0926.
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BAX is a pro-apoptotic member of the Bcl-2 protein family that
normally resides in an inactive state in the cytoplasm of normal cells.
After an apoptotic stimulus, BAX undergoes conformational changes
[1–4], becoming a mediator of the intrinsic phase of apoptosis by its
insertion into mitochondrial membranes, a process that culminates in
release of cytochrome c and activation of effector caspases [5]. One of
the proposed mechanisms that accounts for such an effect is that
oligomeric BAX forms pores in the outermitochondrial membrane [6],
while a second proposal states that BAX induces the opening of the
permeability transition pore (mPTP), inducing mitochondrial swell-
ing, rupture of the outer membrane, and cytochrome c release [7].
Both mechanisms are not necessarily mutually exclusive.
There are evidences that emphasize the importance of the Bcl-2
family protein interactions with and within membranes. It is known,
for example, that members of the Bcl-2 family interact withmitochondrial contact sites [8,9] and induce remodeling of mitochon-
drial membranes [10,11]. Lucken-Ardjomande et al. demonstrated
that cholesterol inhibits BAX activation and oligomerization, although
BAX insertion into the cholesterol-enriched membranes was slightly
increased [12]. Conversely, other groups have shown that cholesterol
reduces the ability of BAX to change from a membrane-associated
protein to a membrane-integral protein. Interestingly, an increased
binding, but a reduced insertion of BAX, has been observed when
cholesterol was added to liposomes or mitochondrial membranes
[13]. Recently, we demonstrated that cholesterol depletion from
isolated mitochondria confers resistance to mPTP opening induced by
recombinant BAX [14] and that endogenous BAX is distributed
preferentially within mitochondrial fractions enriched with choles-
terol and ceramide in the ischemic-reperfused heart [15].
Although it remains unclear how the conformational rearrange-
ments of BAX are regulated to ﬁnally lead to its location within
mitochondrial membranes, the above ﬁndings strongly suggest that
cholesterol or other lipids participate in such processes. In this regard,
it has been reported that several proteins that interact with
cholesterol have an amino acid sequence that is highly conserved
and corresponds to the pattern –L/V-(X)(1–5)-Y-(X)(1–5)-R/K, in
which (X)(1–5) represents between one and ﬁve residues of any
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to propose the existence of a putative cholesterol recognition/
interaction amino acid consensus (CRAC motif) at the α5-helix. We
obtained recombinant BAX mutants in the CRAC motif and deter-
mined their binding, integration, and pore-forming activity in
liposomes supplemented with cholesterol.
2. Materials and methods
Chemicals were of reagent or higher grade from Sigma-Aldrich (St.
Louis, MO, USA), unless otherwise speciﬁed. GST-sepharose, thrombin
protease, and enhanced chemiluminescence system detection were
obtained from Millipore (Bedford, MA, USA); protease inhibitors set
was from Roche (Germany); anti-BAX monoclonal antibody (Clone
6A7) was from Alexis Biochemicals (Axxora, CA, USA), and conjugated
secondary antibodies were from Zymed Laboratories (San Francisco,
CA, USA). Carboxyﬂuorescein was from Molecular Probes (Carlsbad,
CA, USA). Type IV-soybean asolectin containing 25% of phosphatidyl-
choline (PC), cardiolipin (Card), and cholesterol (Chol) were from
Sigma-Aldrich (St. Louis, MO, USA).
2.1. Site-directed mutagenesis
QuickChange site-directed mutagenesis kit from Stratagene (San
Diego, CA, USA) was used to make point mutations in the putative
CRAC motif of recombinant BAX. Brieﬂy, synthetic oligonucleotide
primer pairs containing L113A, Y115F, and K119A point mutations,
each complementary to the opposing strand of the vector, were
extended during temperature cycling by PfuTurbo® DNA polymerase
that produced mutated plasmids containing staggered nicks. Follow-
ing temperature cycling, the products were digested with Dpn I to
select for mutation-containing synthesized DNA. The nicked vectors
were transformed into Escherichia coli. The puriﬁed plasmid se-
quences were analyzed at the DNA Sequence Center of the
Biotechnology Institute (National Autonomous University of Mexico,
UNAM). All genes were entirely sequenced on each strand to verify
that additional mutations had not been introduced by the PCR
ampliﬁcation.
2.2. Puriﬁcation of BAX-ΔC (BAX) protein and BAX mutants
Recombinant GST-BAX-ΔC (protein lacking the C-terminal 20
amino acids) and mutants were prepared according to Xie et al. with
slight modiﬁcations [17]. Brieﬂy, E. coli BL21(DE3)pLysS cells carrying
the plasmid pGEX-4T1-BAX-ΔC were grown at 37 °C in Luria broth
medium supplemented with 100 μg/ml ampicillin, 25 μg/ml chlor-
amphenicol, and 1% glucose, until OD550 was around 0.8. Then,
0.4 mM isopropyl-β-D-thyogalactopiranoside (IPTG) was added and
the cells were cultured overnight at 25 °C. The harvested cells were
disruptedwith lysozyme in the presence of 1% TX100 and sonicated in
a saline-phosphate buffer (PBS), pH 7.4. Unbroken cells were
eliminated after centrifugation at 5000g, for 10 min. A high speed
centrifugation (100,000g for 30 min at 4 °C) was performed to clear
the supernatant, before glutathione-sepharose afﬁnity chromatogra-
phy. Unbound protein was extensively washed using PBS, pH 7.4,
supplemented with 0.1% TX100 and the protein was recovered by
overnight proteolytic cleavage with thrombin at room temperature.
Eluted BAX was dialyzed against 250 volumes of 10 mM Tris/HCl (pH
8.0), 1 mM EDTA, and 0.1% (v/v) 2-β-mercaptoethanol. BAX was
aliquoted and stored at −70 °C.
2.3. BAX oligomerization
BAX oligomerization was induced by incubating the protein with
1% octylglucoside for 60 minutes at 4 °C and then diluted 10 times in
the assay buffer.2.4. Liposomes formation
The lipids were mixed at the ratio 80:12:8 (PC:Card:Chol), dried
under a nitrogen stream, and suspended in PBS, pH 7.4, at a ﬁnal
concentration of 2.5 mg p.l./ml. Liposomes without cholesterol were
supplemented with Type IV-soybean asolectin containing 25% of
phosphatidylcholine (PC) to maintain the same lipid concentration:
88:12 (PC:Card).
We used a modiﬁcation of the freeze–thaw sonication (F/T/S)
method developed by Kasahara and Hinckle [18] and Pick [19], in all
experiments. After sonication, the liposomes were frozen and thawed
ﬁve times, followed by a ﬁnal brief sonication to re-organize the
membranes. The activated protein was incubated with the liposomes
at the indicated concentration for 1 h under constant agitation. Then,
the samples were diluted 15-fold and centrifuged at 100,000g for
45 min. The pellets were suspended in 200 μl of PBS, pH 7.4. The
freezing and thawing process was used to rupture and re-fuse the
small unilamellar vesicles formed by sonication and to increase the
size of the vesicles. For the pore-forming experiments, 800 μl of
liposomes were mixed with 200 μl of 20 mM carboxyﬂuorescein after
sonication and then frozen and thawed during ﬁve cycles. The number
of freeze–thawing cycles was ﬁxed by measuring the increment in
ﬂuorescence under different conditions. The liposomes were sonicat-
ed brieﬂy after the last freeze–thaw cycle, centrifuged at 100,000g
during 45 min, washed, and carefully suspended in 200 μl of PBS,
pH 7.4. We also performed experiments in liposomes prepared by
extrusion with membranes of 0.2 μm size pore. Although liposomes
obtained by this method were 80% homogeneous unilamellar
structures (independently of cholesterol content), with an average
size between 150 and 250 nm (Supplementary Figure S1), they were
smaller than those obtained by the freeze/thaw/sonication method
(0.5–4.4 μm) (Supplementary Figure S2). The ﬂuorescence of the
liposome populations obtained by extrusion was very low, probably
due to the size of the vesicles, precluding the comparison of
membrane surface changes after the reconstitution experiments.
2.5. BAX insertion into cholesterol-enriched liposomes
BAX insertion into liposomes was evaluated by western blot, using
a primary monoclonal anti-BAX antibody (1 μg/ml). Alkaline phos-
phatase conjugated secondary antibodies were used followed by an
enhanced chemiluminescence system detection. Liposomes (1 mg) in
0.5 ml PBS, pH 7.4, were incubated with recombinant BAX at the
indicated concentration for 10 min at room temperature. At this point,
aliquots were withdrawn from the reconstitution mixture, mixed
with sample buffer for electrophoresis, loaded onto SDS-PAGE gels
and stained to verify that protein content was the same in both
preparations (not shown).
To discard the protein loosely bound to the membranes, the
liposomes were incubated with 0.1 M Na2CO3, pH 11.5 (alkaline
extraction), for 10 min more at room temperature. Then, the
liposomes were diluted 10-fold with PBS, pH 7.4, and recovered by
centrifugation at 100,000g for 45 min. The pellets were suspended in
sample buffer for electrophoresis, loaded onto SDS-PAGE gels and
transferred to PVDF membranes for immunodetection using anti-BAX
monoclonal antibodies. In some experiments, SDS-resistant BAX
oligomers were disrupted by treating the samples with triﬂuoroacetic
acid, as described by Sagné et al. [20]. Brieﬂy, BAX samples containing
SDS were treated with anhydrous triﬂuoroacetic acid (TFA) in a 5:1
(v/v) ratio during 15 h and then analyzed by SDS-PAGE.
2.6. Effect of BAX interaction on the ﬂuorescence of liposomes
determined by ﬂow cytometry
To get further information on the effects of mutation of the
conserved amino acids L113A, Y115F, and K119A on BAX interaction
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ﬂow cytometry [21]. Brieﬂy, changes in the mean ﬂuorescence of
liposomes with incorporated wild type BAX and mutants were
analyzed by using a Beckton Dickinson FACSCalibur Flow Cytometer.
Ten thousand liposomes were analyzed using Cell Quest Software at
FL1 compensation of 0.8% and a detector compensation threshold FSC-
H of E00, with the detectors: FSC of 52 V, SCC of 422 V, and FL1 of
412 V. The particles being illuminated one at a time by different lasers
were deﬁned by its granularity (complexity) and by size. In general,
the sideward scatter of laser light (SSC) deﬁne the granularity and
internal complexity of the sample, while the forward scatter (FSC) of
laser light is measured to deﬁne the size of the particle. Settings for
sideward scatter (SSC) were optimized as the noise did not exceed the
ﬁrst log scale, while settings for the forward scatter (FSC) maximized
the particle count within a detectable range. The emitted ﬂuorescence
was ﬁltered to reach the detector channel (FL1). We assumed that
changes in themean ﬂuorescence of the samples representmembrane
surface changes, resulting from protein binding, as reported by
Temmerman and Nickel [22]. Results represent changes in mean
ﬂuorescence, as analyzed by Kolmogorov–Smirnov statistics.2.7. Carboxyﬂuorescein release from cholesterol-enriched liposomes
Liposomes (50–100 μg of p.l.) with entrapped carboxyﬂuorescein
were added to a medium containing 2 ml of phosphate-saline buffer,
pH 7.4. Initial ﬂuorescence, corresponding to vesicle entrapped self-
quenched ﬂuorescent probe (Fo) was determined at λem=488 and
λex=520 in each single trace. Then, the same concentrations of
BAXWT or BAX mutants were used to induce carboxyﬂuorescein
release. At the end of the experiment, 0.05% of TX100 was added to
obtain maximal ﬂuorescence (Fmax). Data are expressed as %F=
[(Ft−Fo) /Fmax−Fo]×100, where Ft is the increase in ﬂuorescence
after 5 min of BAX addition. Ft values were measured after 5 min of
incubation of the vesicles, as maximal response was obtained at this
time using BAX wild type.Table 1
Putative cholesterol recognition/interaction amino acid consensus pattern in different
cholesterol-interacting proteins.
Mouse PBR 147- ATVLNYYVWRDNS
Rat PBR 147-ATMLNYYVWRDNS
Human PBR 147-ATTLNYCVWRDN
Rat P450scc 86-PWVAYHQYYQRPIG
Human P456scc 86-PWVAYHQYYQRPIG
Bovine P450scc 86-PWVAYHZHYQKPVG
Mouse apolipoprotein A-I 207-NPTLNEYHTRAK
Streptococcus cholesterol oxidase 417-ETWVSLYLAITKNP
Nocardia cholesterol dehydrogenase 89-ASVTEAYRQRSFA
Human bile-salt-activated-lipase 222-SLQTLSPYNKGLIRRI
Rabbit acyl-CoA cholesterol acyltransferase 93-STLVVDYIDEGRLV
Human caveolin 91-TFTVTKYWFYR2.8. Docking model of cholesterol into BAX α-5 helix
Three-dimensional models of wild type mouse BAX and mutants
L113A, Y115F and K119A, were obtained with the SWISS-MODEL
software (http://www.swissmodel.expasy.org/) [23,24], using the
crystal structure reported for BAX from Homo sapiens (BAX; accession
number 1F16) as template [25]. Then, theα-5 helix region of BAXwas
taken out from the structure by the use of SPDBV software (http://
www.expasy.org/spdbv/) for docking analysis. The models and the
molecule of cholesterol for docking were prepared using the software
ADT 1.5.2 [26]. Docking of the BAX wild type and mutants with
cholesterol was performed using Autodock 4 (http://www.autodock.
scripps.edu/) [27]. For docking analysis the α5-helix was set as rigid
and cholesterol molecule was set ﬂexible leaving the 6 bonds capable
to rotate as active torsions. One hundred conformations were
obtained and clustered for the analysis and two families of
conformations with different orientation with respect to the α-helix
were obtained. The conformation showing the lowest values of
binding energy and Kd for each family was represented in the docking
model of cholesterol into BAX α5-helix (Fig. 6). Analysis of the
resulting structures and generation of ﬁgures was performed with
PyMOL (http://www.pymol.sourceforge.net/).Mouse BAX 109-VVALFYFASKLVL
Alignment of amino acid sequences of different PBRs in the cholesterol recognition
region; P450sccs in the region corresponding to substrate recognition site 1; and
proteins that interact with cholesterol (obtained from Genebank), containing the
cholesterol recognition/interaction amino acid consensus pattern -L/V-(X)1–5-Y-(X)1–
5-R/K-. A possible CRAC motif in BAX sequence located in α5-helix is also shown. The
conserved amino acids of sequence motif are highlighted and printed over a gray
background. Modiﬁed from Li et al., (2001) Proc. Natl. Acad. Sci. USA. 98: 1267–1272.2.9. Statistical analysis
Values are means±SD and were evaluated by one-way ANOVA
and Tukey's multiple comparative test. P≤0.05 was considered the
threshold for statistical signiﬁcance among the indicated groups.3. Results
3.1. Mutations in the putative CRAC motif of BAX
Residues 113 to 119 of the BAX α5-helix (107-GRVVALFY-
FASKLVL) correspond with the sequence motif described for the
cholesterol recognition/interaction amino acid consensus pattern,
–L/V-(X)(1–5)-Y-(X)(1–5)-R/K. In Table 1, the alignment of amino
acid sequences of different proteins is compared: PBRs in the
cholesterol recognition region, P450sccs in the region of substrate
recognition, other proteins that interact with cholesterol, a segment of
the caveolin sequence, and the putative cholesterol binding domain in
BAX sequence. To test the hypothesis that this sequence corresponds
to a CRAC motif, we modiﬁed the three conserved amino acids of the
domain. Mutations were introduced by PCR; leusine-113 and lysine-
119 were changed to the uncharged residue alanine, and tyrosine-115
was changed to phenylalanine: L113A, Y115F, and K119A (Fig. 1).
3.2. BAX mutants insertion into liposomes
Hydrophobic domains previously folded back within the protein
are known to be exposed by non-ionic detergent treatment, inducing
BAX oligomerization. Octylglucoside (1%) was incubated with BAXWT
and the mutants. The oligomerized state was preserved after SDS-
PAGE and, only under extremely de-aggregating conditions, the
monomeric form was recovered. Fig. 2A shows the formation of SDS-
resistant BAX oligomers of BAXWT and its dissociation with triﬂuor-
oacetic acid (TFA). It also shows that the mutants retained the
oligomerization properties of BAXWT, after non-ionic detergent
activation (Fig. 2B).
Next, we determined the effect of the putative consensus CRAC
motif included in the BAXWT sequence and the afﬁnity of this protein
to cholesterol, bymeasuring the insertion of the wild type protein into
liposomes without cholesterol and into liposomes supplemented with
cholesterol. According to Ardail et al. [28], cholesterol content in the
outer membrane represents 7.1 in percent by weight of total lipids; in
that work, the outer membrane contact sites were found to possess a
higher ratio of cholesterol/phospholipid than the inner membrane
contact sites. In our experiments, cholesterol is expected to be
distributed randomly along the liposomemembrane, thus we decided
to use cholesterol at 8% in weight of total lipids. BAXWT association
(binding) into the membranes was the same in both types of
liposomes; however, after ionic detachment with Na2CO3, it was
observed that BAXWT maintained stronger interaction with
105                                                  135 
α5
BAXWT         FNWGRVVALFYFASKLVLKALCTKVPELIRT
CRAC DOMAIN
BAXY115F      FNWGRVVALFFFASKLVLKALCTKVPELIRT
BAXK119A      FNWGRVVALFYFASALVLKALCTKVPELIRT 
BAXL113A      FNWGRVVAAFYFASKLVLKALCTKVPELIRT 
Fig. 1. Partial sequence of the CRAC motif in BAX wild type and mutants. The fragment
from residues 105 to 135 of mouse BAX is shown, which includes residues of the α-5
helix, according to TopPred II (Claros and von Heijne), highlighted in white over a black
background. Aligned are the sequences of the studied mutants, residues substituted
with respect to the wild-type sequence are printed over a light grey background.
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weak association between BAX and lipids occurs preferentially along
the membrane in liposomes without cholesterol. Conversely, the BAX
proteins that interact with cholesterol in the membrane would beFig. 2. Cholesterol increases BAXWT insertion into liposomes. Representative immunoblots s
oligomerization properties (B). Panel C shows BAXWT reconstitution into liposomes enrich
Na2CO3. The liposomes were incubated with 0.1 M Na2CO3, pH 11.5 (alkaline extraction), for
pH 7.4, and recovered by centrifugation at 100,000g for 45 min. The pellets were suspended i
membranes for immunodetection using anti-BAX monoclonal antibodies. A representative
different preparations are shown. (*P≤0.05 vs. BAXWT insertion in liposomes without choltightly bounded and become more resistant to ionic removal from
liposomes enriched with cholesterol. By these reasoning we conclud-
ed that in such liposomes, a stronger interaction of BAX avoids Na2CO3
detachment from the membrane.
The cholesterol-dependent insertion of the mutants was also
analyzed. Results were expressed in percentages to normalize the
chemiluminescence signal in each blot, for each peptide, and to
eliminate background differences between individual plates, or
possible changes in the recognition response of the antibody to each
peptide.
The cholesterol-dependent insertion increment observed in the
wild type, although less impressive, was maintained in the mutant
K119A, but was not observed in either Y115F or L113Amutant. Both of
them showed similar insertion into liposomes regardless of the
cholesterol content (Fig. 3). Thus, while it is likely that cholesterol
plays a role in BAXWT and K119A mutant insertion, this behavior is
reduced in mutants Y115F and L113A.
3.3. Membrane surface effects in liposomes induced by interactions
between lipids and BAX
In the absence of protein, the vesicles showed different mean
ﬂuorescence values, depending on the presence of cholesterol. Inhowing the dissociation of BAXWT oligomers after TFA treatment (A), and BAX mutants
ed with cholesterol without any treatment (bound) and after alkaline extraction with
10 min more at room temperature. Then, the liposomes were diluted 10-fold with PBS,
n sample buffer for electrophoresis, loaded onto SDS-PAGE gels and transferred to PVDF
immunoblot and the histogram quantiﬁcation (Panel D) of three experiments with
esterol).
Fig. 3. BAX mutants insertion into liposomes enriched with cholesterol. Left panel: Representative immunoblots of BAXWT, Y115F, K119A, and L113A insertion into PC:Card and PC:
Card:Chol liposomes. Right panel: Histogram plots showing quantiﬁcation of three different immunoblots. BAXWT and mutants immunodetection in liposomes without cholesterol
was normalized as 100% and compared to the signal obtained in cholesterol-enriched liposomes for each protein. (*P≤0.05).
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enrichedwith cholesterol, suggesting variations in bilayer complexity.
Accordingly, changes in mean ﬂuorescence within each type of
liposomes promoted by BAXWT and mutants interaction were
evaluated. In Fig. 4B it is shown that BAXWT and all mutants
diminished signiﬁcantly the mean ﬂuorescence of PC:Card liposomes
(D=0.12 to 0.20 at P≤0.001). Conversely, in PC:Card:Chol liposomes,
BAXWT and L113A mutant, promoted an increase in the mean
ﬂuorescence of the vesicles (D=0.1 and D=0.06 respectively),
whereas the mean ﬂuorescence in liposomes with reconstituted
Y115F and K119A was lower than that observed in the liposomesA B
D=0.19
P≤0.001
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Fig. 4. Flow cytometric analysis of interactions between liposome lipids and BAX wild ty
population of PC:Card (black) and PC:Card:Chol (red) liposomes calculated by Kolmogorov–
after protein interaction in PC:Card (green) and PC:Card:Chol (blue) liposomes. D, refers
λEx=530 nm and λEm=488 nm.without protein (D=0.06–0.07 at P≤0.001). From results shown in
Figs. 3 and 4, we concluded that Tyr115 is more relevant to
cholesterol-dependent insertion of BAX, than Leu113 or Lys119.
3.4. Effect of cholesterol on pore formation by BAX mutants in liposomes
Activated BAXWT induced carboxyﬂuorescein (CF) leakage in both
types of liposomes. This concentration-dependent release was slightly
enhanced in cholesterol-enriched liposomes (Fig. 5A), possibly
reﬂecting the favored insertion of the protein when cholesterol is a
component of the bilayer (Fig. 3). All the mutants induced aD=0.12
P≤0.001
D=0.19
P≤0.001
D=0.15
P≤0.001
D=0.2
P≤0.001
D=0.1
P≤0.001
D=0.07
P≤0.001
D=0.06
P≤0.001
D=0.07
P≤0.001
pe and mutants. (Panel A) Histogram overlay and mean ﬂuorescence of the vesicle
Smirnov statistical analysis in absence of protein. (Panel B) Mean ﬂuorescence changes
to the difference on a logarithmic scale between liposomal populations at P≤0.001.
Fig. 5. Carboxyﬂuorescein release from liposomes enriched with cholesterol induced by BAXWT and mutants. Liposomes (50–100 μg lipids) with entrapped carboxyﬂuorescein were
added to a phosphate-saline buffer, pH 7.4. The ﬂuorescent probe release was induced by adding the indicated BAXWT and mutant concentrations. Data represent the mean±S.D. of
three different experiments; black bars, liposomes without cholesterol; white bars, liposomes enriched with cholesterol.
1893E. Martínez-Abundis et al. / Biochimica et Biophysica Acta 1808 (2011) 1888–1895diminished carboxyﬂuorescein leakage as compared with the wild
type (Fig. 5B, C and D). Fluorescence release at 40 nM concentration
was 32% in Y115F; 42% in K119A and 49% in L113A versus 70.8%
induced by the wild type protein in cholesterol-enriched liposomes.
This suggests that although mutations of the putative CRAC motif in
BAX have no effect on the oligomerization properties of the protein
(Fig. 2B), the resulting structures have a diminished efﬁciency in
forming a pore, as compared with the wild type protein.
3.5. Docking model of cholesterol into a CRAC motif signature included in
BAX α-5 helix
The α5-helix conformation of BAXWT containing the CRAC domain
was analyzed in light of the crystal structure reported for BAX from
Homo sapiens. According to previous reports, the transmembrane
domain of BAX is predicted to form a helix from residue 108 up to 126
[29,30]. Multiple conformations of cholesterol into the putative CRAC
motif in BAXWTα5-helix were analyzedwith Autodock 4. The docking
analysis of cholesterol with BAXWT α5-helix rendered two main
families of conformations, which account for the accommodation of
cholesterol (Fig. 6). Conformations with the lower binding constants
and lower binding energies for each family (Kd=50.6 μM,−5.86kCal/
mol and Kd=43.2 μM, −5.95kCal/mol) were selected (Table 2). The
conformations inwhich the cholesterol molecule ﬁts into two possible
cavities were deﬁned arbitrarily as “a” and “b.” In the ﬁrst cavity,
formed by A112, L113, and F116, the small polar head of cholesterol
could be located, close to R109 in the a conformation. The second
groove (b conformation) is formed by Y115, F116, and L120 (Fig. 6)
with the 3'OH group of cholesterol facing the opposite side of BAX
structure. Docking analysis was also carried out with the BAXmutants
(Supplementary Figure S5). For all mutants the values of binding
energy as well as Kd were increased in both cholesterol conformations
(Table 2). Interestingly, mutants Y115F and L113A showed the highestincrease in binding energy and Kd for both conformations, consistent
with the diminution on cholesterol-dependent insertion into the
membrane of these mutants (Fig. 3), compared to BAXWT.
4. Discussion
The hypothesis that Bcl-2 family members are activated and dock
at the mitochondrial outer membrane in response to a particular
membrane environment has been proposed by different research
groups. For example, Kim et al. showed that tBid binds to cardiolipin
at the mitochondrial contact sites [31]. Another report indicates that
cardiolipins are essential for α-6 helix tBid binding, and that both
electrostatic interactions and lipid organization play a crucial role for
tBid to penetrate into the membrane [32,33]. Cardiolipin is also
relevant for BAX activation and for binding of the ﬁrst helix of the
protein to the mitochondrial membrane [34]. In this context, results
from our laboratory showed coexistence in mitochondrial detergent-
resistant membranes (MDRM) of BAX and cholesterol, along with
contact sites forming proteins, e.g. ANT and VDAC. We also observed
that cholesterol extraction frommitochondrial membranes, promoted
a marked diminution in BAX insertion and inhibition of cytochrome c
release. Accordingly, we proposed that modiﬁcations in the choles-
terol content could lead to alterations in the physical environment of
the membrane, consequently changing the chance of certain proteins
to partition into cholesterol enriched domains [15].
To this respect, it is known that some proteins share a common
amino acid consensus pattern that favors their association with
cholesterol. This domain consists of a neutral and hydrophobic amino
acid, such as leucine or valine, a neutral and polar amino acid, like
tyrosine, and a basic amino acid, such as arginine or lysine. It has been
proposed that leucine or valine would interact with the hydrophobic
side chain of cholesterol, whereas tyrosine would interact with the
polar 3'OH-group of cholesterol and arginine or lysine may help to
Fig. 6. Docking of cholesterol on helix α-5 of BAX. Alpha-5 helix of BAX, which contains
the putative CRAC domain, was used to develop a model of possible interactions with
cholesterol (yellow). In A and B, it is shown the ribbon presentation of the helix, with
the side chain of some amino acids represented as sticks of the two most favored
conformations of cholesterol found by docking (lowest Kd and binding energy values)
and the surface representations of the same helix. It can be appreciated that the side
chain of the amino acids in the helix form a groove into which cholesterol ﬁts. Figures
were prepared using PyMOL, as described under Materials and methods. Arrows
indicate the position of important amino acids presented as one letter symbols. The
complete sequence of the helix is depicted on the top of the ﬁgure and the CRAC domain
is shown highlighted.
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that mutations in Tyr115 and Leu113 changed the cholesterol-
dependent insertion observed in the wild type protein by western
blot analysis (Fig. 3), whereas ﬂuorescence changes exerted by BAXWT
in cholesterol-enriched liposomes were higher than those promoted
by the mutants (Fig. 4). Besides, the pore properties of the mutants
diminished as compared to the wild type, independently from the
cholesterol content in the membranes. However, the release of the
entrapped substrate showed a tendency to increase in cholesterol-
enriched liposomes at least in the wild type (Fig. 5).
In a putative CRAC motif, the side-chains of aromatic amino acids
would facilitate interaction with the relatively ﬂat structure of
cholesterol. After clustering analysis, we obtained two conformations
with the lowest energy (Kd) for cholesterol docking into BAXα5-helix.Table 2
Values of binding energy and Kd obtained from the docking of cholesterol on α-5 helix
of BAXWT and the different mutants.
BAX Cholesterol alignment⁎ Binding energy (kCal) Kd (μM)
WT a −5.86 50.6
b −5.95 43.2
Y115F a −5.67 70.4
b −5.58 81.2
K119A a −5.82 54.1
b −5.38 113.2
L113A a −5.23 146.8
b −5.38 113.1
⁎ a and b refer to the two families of conformations found in the docking analysis and
represent the conformation of lowest energy of binding and Kd for each family. These
conformations are shown in Fig. 6 and Supplemental Figure 5.In one of them, cholesterol is located close to Arg109 in the α-5 helix
of BAXWT, and the groove could be formed by Leu113, Tyr115, and
Phe116 (Fig. 6A, B). Tyr115 could interact with the side chain of
Lys119, stabilizing the caveat. By eliminating the reactive group in the
Y115F mutation, this stabilization could be lost, partially explaining
the difference in the insertion properties between this mutant and the
wild type. As for L113A, the insertion properties were also modiﬁed,
although no relevant changes were observed in the mean ﬂuores-
cence of liposomes after reconstitution.
In a second favorable conformation, the cavity could be formed by
Tyr115, Leu119, and Lys120 (Fig. 6C and D), albeit, in this
conformation, the only possible interaction of the cholesterol polar
group would be with Lys123. In contrast with other proposals, as
those reported for the CRAC motif of the peripheral-type benzodiaz-
epine receptor [35] and for HIV gp41 peptides [36], our model does
not support critical interactions of the central tyrosine residue with
the cholesterol hydroxyl group. In such models, electrostatic and
hydrophobic interactions between the central tyrosine in the motif
and cholesterol are possibly due to the location of this residue in the
boundary region of the membrane interface.
We are aware of the limitations of the proposed model, as the
water-soluble structure used here is the only one structure available
for BAX. However, we used this structure as the docking target for our
study, as it has been predicted that the ﬁrst fragment of the hairpin of
BAX, namely α -helices 5 and 6, has a predominantly α-helical
structure in lipid-mimetic and lipid environments [37]. Thus, this
model should be taken cautiously as it only represents an illustration
of the possible interactions of the peptides with cholesterol, but that
behavior could be different in the membrane. Considering that in the
formation of a pore, several BAX molecules must be involved, the
polar residues imbibed into the lipid belayed could be interactingwith
charged residues of other BAX molecules to stabilize the oligomer in
the membrane, thus substitutions in the peptide structure could
account for reduced efﬁciency in pore formation and in consequently
in pore activity.
Variable effects of mutants on mean liposome ﬂuorescence open
the possibility that the presence of a CRAC sequence could be only one
of multiple factors that contribute to enhance protein binding into
cholesterol-rich domains. A good example of the aforementioned is
caveolin, which possesses a CRAC sequence and also has three
palmitoyl groups [38,39]. Among the different proteins associated to a
CRAC motif, caveolin constitutes a bona ﬁde marker for a type of
cholesterol-rich domain in biological membranes. Epand et al. studied
segments of this protein that correspond to a CRAC motif. Although
these peptides promote the segregation of cholesterol into domains
from mixtures of the sterol with phosphatidylcholine, the authors
concluded that the presence or absence of a CRAC motif is not a
sufﬁcient criterion to determine the extent to which a protein will
promote the segregation of cholesterol in membranes [40].
As mentioned above, other features that promote the partition of
proteins into cholesterol-rich domains are certain types of lipidation.
In this sense, Sakurai et al. described post-transcriptional myristoyla-
tion in tBid [41], however, mutations of the myristoylation site in tBid,
which indeed suppress myristoylation capabilities, do not affect the
interaction of tBid with mitochondria. Although it is known that
palmitoylated proteins are generally found in the raft fraction of
membranes enriched with cholesterol [42], there are no evidences of
such post-translational modiﬁcations in BAX structures. Another
explanation of our results, besides the possible structural features
already mentioned, could be the existence of interactions or
conformations in the intact oligomeric protein that could not be
reproduced in our experimental design. Indeed, there are reports that
segments in gp41 proteins, which do not have formally a CRAC
sequence, are also likely targeted to raft domains [43].
Summarizing, our experiments add new information to the
possible components of the machinery of BAX membrane
1895E. Martínez-Abundis et al. / Biochimica et Biophysica Acta 1808 (2011) 1888–1895permeabilization mechanism. Beyond the proposal that the critical
event for BAX membrane permeabilization function is the transition
from a membrane-integrated ‘monomer’ to a detergent-resistant
oligomeric form [44], we propose that the insertion mechanism
involves lipid organization in the membrane and that a sequence that
corresponds to a cholesterol recognition/interaction amino acid
consensus motif in BAX contributes to the incorporation of proteins
into cholesterol-enriched membranes, although this interaction could
be increased by other factors.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.03.008.
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